Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 15, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Third Quarter 2012 Financial Results

CORAL GABLES, Fla., Nov. 15, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the third quarter and nine months ended September...
November 08, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II(b) Trial for Cocaine Addiction

CORAL GABLES, Fla., Nov. 8, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced top-line results from its U.S. Phase II(b) clinical trial evaluating the use...
October 31, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners and BioMarin Pharmaceutical Enter Into Strategic Collaboration for Firdapse(TM) in North America

BioMarin to Make $5 Million Strategic Equity Investment in Catalyst Catalyst Licenses North American Rights to Firdapse™, a Phase III Orphan Drug for the Treatment of Lambert-Eaton...
September 26, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Updates Guidance on Timing of Top-Line Data From CPP-109 Phase II(b) Clinical Trial for the Treatment of Cocaine Addiction

CORAL GABLES, Fla., Sept. 26, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has been advised by the Department of Veterans Affairs Cooperative...
September 24, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Commencement of CPP-109 Investigator-Sponsored Study in Patients With Treatment Refractory Tourette's Disorder

CORAL GABLES, Fla., Sept. 24, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that researchers at Mount Sinai School of Medicine in New York have...
September 06, 2012 18:45 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners to Present at Rodman & Renshaw's 14th Annual Healthcare Conference

CORAL GABLES, Fla., Sept. 6, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that Patrick J. McEnany, Chief Executive Officer, will be presenting at...
August 30, 2012 15:21 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Announces Closing of Previously Announced $6 Million Registered Direct Offering

CORAL GABLES, Fla., Aug. 30, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has closed its previously announced offering of (i) 4.0 million...
August 28, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners, Inc. Raises $6 Million in Registered Direct Offering

CORAL GABLES, Fla., Aug. 28, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has entered into definitive agreements to sell (i) 4.0 million shares...
August 15, 2012 08:03 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Announces Second Quarter 2012 Financial Results

CORAL GABLES, Fla., Aug. 15, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced its financial results for the second quarter and six months ended June 30,...
August 03, 2012 09:04 ET | Source: Catalyst Pharmaceuticals, Inc.

Catalyst Pharmaceutical Partners Regains Compliance With NASDAQ Minimum Bid Price Rule

CORAL GABLES, Fla., Aug. 3, 2012 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) announced today that it has received notice from the NASDAQ Stock Market ("NASDAQ") confirming...